Amarantus Bioscience Holdings Stock Price, News & Analysis (OTCBB:AMBS)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Amarantus Bioscience Holdings (OTCBB:AMBS)

Amarantus Bioscience Holdings logoAmarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a small molecule drug for the treatment of Parkinson’s disease Levadopa-Induced Dyskinesia and attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including retinitis pigmentosa and retinal artery occlusion. It also develops NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson’s disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. In addition, the company develops Engineered Skin Substitute (ESS), a cell therapy-based autologous skin replacement product that is in mid-stage clinical development for the treatment of life-threatening severe burns. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus Bioscience Holdings, Inc. in April 2013. Amarantus Bioscience Holdings, Inc. was founded in 2008 and is based in San Francisco, California.


Industry, Sector and Symbol:
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Sector: Healthcare
  • Symbol: OTCBB:AMBS
  • CUSIP: N/A
  • Web: www.amarantus.com
 

Frequently Asked Questions for Amarantus Bioscience Holdings (OTCBB:AMBS)

What is Amarantus Bioscience Holdings' stock symbol?

Amarantus Bioscience Holdings trades on the OTCBB under the ticker symbol "AMBS."

How were Amarantus Bioscience Holdings' earnings last quarter?

Amarantus Bioscience Holdings, Inc (OTCBB:AMBS) posted its quarterly earnings results on Monday, November, 23rd. The company reported ($0.98) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.77) by $0.21. View Amarantus Bioscience Holdings' Earnings History.

Who are some of Amarantus Bioscience Holdings' key competitors?

How do I buy Amarantus Bioscience Holdings stock?

Shares of Amarantus Bioscience Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.


MarketBeat Community Rating for Amarantus Bioscience Holdings (OTCBB AMBS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  48
MarketBeat's community ratings are surveys of what our community members think about Amarantus Bioscience Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Amarantus Bioscience Holdings (OTCBB:AMBS)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 0 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.00)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Amarantus Bioscience Holdings (OTCBB:AMBS)

Price Target History for Amarantus Bioscience Holdings (OTCBB:AMBS)

Analysts' Ratings History for Amarantus Bioscience Holdings (OTCBB:AMBS)

Show:
DateFirmActionRatingPrice TargetDetails
12/7/2016WallachBeth CapitalDowngradeBuy -> HoldView Rating Details
(Data available from 11/21/2015 forward)

Earnings

Earnings History and Estimates Chart for Amarantus Bioscience Holdings (OTCBB:AMBS)

Earnings by Quarter for Amarantus Bioscience Holdings (OTCBB:AMBS)

Earnings History by Quarter for Amarantus Bioscience Holdings (OTCBB AMBS)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/23/2015Q3($0.77)($0.98)ViewN/AView Earnings Details
8/17/2015Q2 2015($1.49)($1.08)ViewN/AView Earnings Details
11/17/2014Q3 14($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Amarantus Bioscience Holdings (OTCBB:AMBS)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Amarantus Bioscience Holdings (OTCBB:AMBS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Amarantus Bioscience Holdings (OTCBB AMBS)

Insider Trades by Quarter for Amarantus Bioscience Holdings (OTCBB:AMBS)

Insider Trades by Quarter for Amarantus Bioscience Holdings (OTCBB AMBS)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2015Robert Lewis HarrisDirectorBuy19,500$0.48$9,360.00View SEC Filing  
4/9/2015Robert Edward FarrellCFOBuy200,000$0.05$10,000.00View SEC Filing  
4/8/2015Gerald CommissiongCEOBuy240,000$0.05$12,000.00View SEC Filing  
11/20/2014Gerald CommissiongCEOBuy130,000$0.08$10,400.00View SEC Filing  
11/19/2014Robert Edward FarrellCFOBuy133,333$0.08$10,666.64View SEC Filing  
1/17/2014Gerald CommissiongCEOBuy50,000$0.09$4,500.00View SEC Filing  
4/30/2013Gerald CommissiongCEOBuy50,000$0.05$2,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Social Media

Social activity is not available for this stock.

Financials

Chart

Amarantus Bioscience Holdings (OTCBB AMBS) Chart for Tuesday, November, 21, 2017
Loading chart…

This page was last updated on 11/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.